Australia markets closed

Vivozon Pharmaceutical Co., Ltd. (082800.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
3,110.00-40.00 (-1.27%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-2,185,638
-3,357,006
-39,905,817
-69,456,962
-43,754,179
-
Depreciation & amortisation
3,063,867
3,227,940
3,643,466
5,552,164
2,179,325
-
Stock-based compensation
-
-
-51,010
277,473
195,959
-
Change in working capital
-6,220,803
-4,452,633
4,067,298
-9,182,359
6,066,418
-
Inventory
-4,544,815
-3,664,547
2,749,857
-3,756,019
713,039
-
Other working capital
-5,526,677
-3,678,528
-11,966,702
-29,543,771
3,427,944
-
Other non-cash items
1,983,554
2,222,331
4,561,687
6,231,179
8,839,271
-
Net cash provided by operating activities
3,320,020
2,991,686
-3,323,460
-17,496,245
4,624,820
-
Cash flows from investing activities
Investments in property, plant and equipment
-8,846,697
-6,670,214
-8,643,242
-12,047,526
-1,196,876
-
Acquisitions, net
-
-
-60,644,591
-213,044
-56,368,406
-12,041,814
Purchases of investments
-3,053,800
-3,336,000
-4,355,630
-29,963,000
-100,301,950
-
Sales/maturities of investments
16,922,020
17,222,020
38,120,394
5,914,706
94,095,339
-
Other investing activities
209,397
332,262
-169,414
-9,195,525
1,831,629
-
Net cash used for investing activities
15,413,002
19,308,713
-34,552,096
-47,128,299
-64,183,718
-
Net change in cash
534,414
5,635,365
-11,447,537
-50,532,544
7,000,307
-
Cash at beginning of period
2,866,534
2,351,141
13,798,678
64,331,222
57,330,916
-
Cash at end of period
3,401,831
7,986,506
2,351,141
13,798,678
64,331,222
-
Free cash flow
Operating cash flow
3,320,020
2,991,686
-3,323,460
-17,496,245
4,624,820
-
Capital expenditure
-8,846,697
-6,670,214
-8,643,242
-12,047,526
-1,196,876
-
Free cash flow
-5,526,677
-3,678,528
-11,966,702
-29,543,771
3,427,944
-